Responding to Ontario’s overdose crisis in the context of the COVID-19 pandemic
Gomes T, Kitchen S, Campbell T, Murray R, Leece P, Kolla G; Ontario Opioid Drug Observatory. Healthc Q. 2022; 25(2):7-12. Epub 2022 Jul 1.
Publications
Association of obstructive sleep apnea and opioids use on adverse health outcomes: a population study of health administrative data
Kendzerska T, Gomes T, Malhotra A, Gershon AS, Povitz M, McIsaac DI, Aaron SD, Chung F, Bryson GL, Talarico R, Ahmed T, Godbout M, Tanuseputro P. PLoS One. 2022; 17(6):e0269112. Epub 2022 Jun 28.
Categorization of opioid use among pregnant people and association with overdose or death
Camden A, To T, Ray JG, Gomes T, Bai L, Guttmann A. JAMA Netw Open. 2022; 5(5):e2214688. Epub 2022 May 27.
Evaluating the population-level effects of oxycodone restrictions on prescription opioid utilization in Ontario
Rudoler D, Kurdyak P, Gomes T, Huang A, Jones W, Littleford S, Paracha N, Fischer B. Pharmacoepidemiol Drug Saf. 2022; 31(7):769-78. Epub 2022 Apr 26.
Risk of suicide death following electroconvulsive therapy treatment for depression: a propensity score-weighted, retrospective cohort study in Canada
Kaster TS, Blumberger DM, Gomes T, Sutradhar R, Wijeysundera DN, Vigod SN. Lancet Psychiatry. 2022; 9(6):435-46. Epub 2022 Apr 26.
Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: a population-based study
Antoniou T, Men S, Tadrous M, Leece P, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109473. Epub 2022 Apr 26.
Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: a population-based time series analysis
Garg R, Kitchen SA, Men S, Campbell TJ, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109459. Epub 2022 Apr 14.
Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions
Bouck Z, Scheimac AI, Gomes T, Ling V, Caudarella A, Werb D. Int J Drug Policy. 2022; 104:103680. Epub 2022 Apr 13.
Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: a cross-sectional study
Konstantelos N, Shakeri A, McCormack D, Campos-Meade A, Gomes T, Murti M, Pierre-Pierre V, Tadrous M. Can Commun Dis Rep. 2022; 48(4):170-8. Epub 2022 Apr 1.
The risk of ventricular dysrhythmia or sudden death in patients receiving serotonin reuptake inhibitors with methadone: a population-based study
Antoniou T, McCormack D, Tadrous M, Juurlink DN, Gomes T. Front Pharmacol. 2022; 13:861953. Epub 2022 Mar 11.